Archive for September, 2009

Journal of Commercial Biotechnology — October 2009 issue now available

The October 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 15, Issue 4 Editorial Intellectual property and biotechnology innovation: To protect or not protect? PDF Yali Friedman Commentary The correlation between medical tourism and biotechnology PDF David G Vequist […]

Pfizer's Power on Individualized Medicine

In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s genome is sequenced and drug prescriptions are based on your genetic makeup, and argues that personalized medicine will be the defining paradigm for discovering and developing drugs of the future. To put these videos into […]

Introducing DCbiotech — High-level networking in the nation's capital

DCbiotech is a high-level networking group based in Washington DC. The objective is to bring together individuals working in, or serving, the biotechnology sector in Washington DC. For more information, please visit . The first meeting is scheduled for September 15th. Full details and the RSVP form are available here.

Drug Patent Expirations in September 2009

Courtesy of Drug Patent Expirations in September 2009 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration FARESTON Gtx Inc toremifene citrate 4,696,949 Sep 29, 2009 FELBATOL Meda Pharms felbamate 4,978,680 Sep 26, 2009 FELBATOL Meda Pharms felbamate 5,082,861 Sep 26, 2009 GLUCOTROL XL Pfizer glipizide 5,024,843 Sep […]